1. Barnes, P.J., et al., Chronic obstructive pulmonary disease. Nat Rev Dis Primers, 2015. 1: p. 15076.
2. Zuo, L., et al., Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. Am J Physiol Lung Cell Mol Physiol, 2014. 307(3): p. L205-18.
3. Barnes, P.J., Targeting cytokines to treat asthma and chronic obstructive pulmonary disease. Nat Rev Immunol, 2018. 18(7): p. 454-466.
4. Barnes, P.J., Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med, 2010. 7(3): p. e1000220.
5. Perera, W.R., et al., Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J, 2007. 29(3): p. 527-34.
6. Chen, Y.W., J.M. Leung, and D.D. Sin, A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation. PLoS One, 2016. 11(7): p. e0158843.
7. Kadota, T., et al., Extracellular Vesicles in Chronic Obstructive Pulmonary Disease. Int J Mol Sci, 2016. 17(11).
8. EL Andaloussi, S., et al., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov, 2013. 12(5): p. 347-57.
9. Yanez-Mo, M., et al., Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles, 2015. 4: p. 27066.
10. van der Pol, E., et al., Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev, 2012. 64(3): p. 676-705.
11. Javeed, N. and D. Mukhopadhyay, Exosomes and their role in the micro-/macro-environment: a comprehensive review. J Biomed Res, 2017. 31(5): p. 386-394.
12. Atkin-Smith, G.K., et al., Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting. Sci Rep, 2017. 7: p. 39846.
13. Yang, J., et al., Importance of indoor dust biological ultrafine particles in the pathogenesis of chronic inflammatory lung diseases. Environmental health and toxicology, 2017. 32: p. e2017021-e2017021.
14. Thery, C., et al., Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles, 2018. 7(1): p. 1535750.
15. Takahashi, T., et al., Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro. Exp Lung Res, 2013. 39(4-5): p. 155-61.
16. Strulovici-Barel, Y., et al., Persistence of circulating endothelial microparticles in COPD despite smoking cessation. Thorax, 2016. 71(12): p. 1137-1144.
17. Thomashow, M.A., et al., Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study. Am J Respir Crit Care Med, 2013. 188(1): p. 60-8.
18. Garcia-Lucio, J., et al., Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS One, 2018. 13(4): p. e0195724.
19. Barak, O.F., et al., Disturbed blood flow worsens endothelial dysfunction in moderate-severe chronic obstructive pulmonary disease. Sci Rep, 2017. 7(1): p. 16929.
20. Liu, H., et al., Circulating endothelial microparticles involved in lung function decline in a rat exposed in cigarette smoke maybe from apoptotic pulmonary capillary endothelial cells. J Thorac Dis, 2014. 6(6): p. 649-55.
21. Benedikter, B.J., et al., Cigarette smoke extract induced exosome release is mediated by depletion of exofacial thiols and can be inhibited by thiol-antioxidants. Free Radic Biol Med, 2017. 108: p. 334-344.
22. Moon, H.-G., et al., CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke. American journal of physiology. Lung cellular and molecular physiology, 2014. 307(4): p. L326-L337.
23. Genschmer, K.R., et al., Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung. Cell, 2019. 176(1-2): p. 113-126 e15.
24. Feller, D., et al., Cigarette Smoke-Induced Pulmonary Inflammation Becomes Systemic by Circulating Extracellular Vesicles Containing Wnt5a and Inflammatory Cytokines. Front Immunol, 2018. 9: p. 1724.
25. Colombo, M., G. Raposo, and C. Thery, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol, 2014. 30: p. 255-89.
26. He, S., et al., Bronchial epithelial cell extracellular vesicles ameliorate epithelial-mesenchymal transition in COPD pathogenesis by alleviating M2 macrophage polarization. Nanomedicine, 2019. 18: p. 259-271.
27. Xu, H., et al., Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking. Theranostics, 2018. 8(19): p. 5419-5433.
28. Fujita, Y., et al., Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis. J Extracell Vesicles, 2015. 4: p. 28388.
29. Serban, K.A., et al., Structural and functional characterization of endothelial microparticles released by cigarette smoke. Sci Rep, 2016. 6: p. 31596.
30. Kim, J.H., et al., Gram-negative and Gram-positive bacterial extracellular vesicles. Semin Cell Dev Biol, 2015. 40: p. 97-104.
31. Kim, Y.S., et al., Extracellular vesicles derived from Gram-negative bacteria, such as Escherichia coli, induce emphysema mainly via IL-17A-mediated neutrophilic inflammation. J Immunol, 2015. 194(7): p. 3361-8.
32. Kim, H.J., et al., The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients. 2017. 49(4): p. e316.
33. Kim, Y.S., et al., IgG Sensitization to Extracellular Vesicles in Indoor Dust Is Closely Associated With the Prevalence of Non-Eosinophilic Asthma, COPD, and Lung Cancer. Allergy Asthma Immunol Res, 2016. 8(3): p. 198-205.
34. Yang, J., et al., Lung Disease Diagnostic Model Through IgG Sensitization to Microbial Extracellular Vesicles. Allergy Asthma Immunol Res, 2020. 12(4): p. 669-683.
35. Takahashi, T., et al., Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax, 2012. 67(12): p. 1067-74.
36. Eltom, S., et al., Respiratory infections cause the release of extracellular vesicles: implications in exacerbation of asthma/COPD. PLoS One, 2014. 9(6): p. e101087.
37. Tan, D.B.A., et al., Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation. Respir Med, 2017. 132: p. 261-264.
38. Tokes-Fuzesi, M., et al., Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 2018. 13: p. 3749-3757.
39. Mirza, S., et al., COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin Proc, 2018. 93(10): p. 1488-1502.
40. Lacedonia, D., et al., Microparticles in sputum of COPD patients: A potential biomarker of the disease? International Journal of COPD, 2016. 11(1): p. 527-533.
41. Gordon, C., et al., Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. American journal of respiratory and critical care medicine, 2011. 184(2): p. 224-232.
42. Takahashi, T., et al., Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study. BMJ Open, 2014. 4(3): p. e004571.
43. Sundar, I.K., D. Li, and I. Rahman, Small RNA-sequence analysis of plasma-derived extracellular vesicle miRNAs in smokers and patients with chronic obstructive pulmonary disease as circulating biomarkers. J Extracell Vesicles, 2019. 8(1): p. 1684816.
44. Jung, A.L., et al., Surface Proteome of Plasma Extracellular Vesicles as Biomarkers for Pneumonia and Acute Exacerbation of Chronic Obstructive Pulmonary Disease. J Infect Dis, 2020. 221(2): p. 325-335.
45. Green, C.E. and A.M. Turner, The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD). Respir Res, 2017. 18(1): p. 20.
46. Moro, L., et al., Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology, 2008. 59(3): p. 357-64.
47. Clarenbach, C.F., N.A. Sievi, and M. Kohler, Annual progression of endothelial dysfunction in patients with COPD. Respir Med, 2017. 132: p. 15-20.
48. Taylor, J.D., COPD and the response of the lung to tobacco smoke exposure. Pulm Pharmacol Ther, 2010. 23(5): p. 376-83.
49. Singh, D., Chronic Obstructive Pulmonary Disease, Neutrophils and Bacterial Infection: A Complex Web Involving IL-17 and IL-22 Unravels. EBioMedicine, 2015. 2(11): p. 1580-1.
50. Crotty Alexander, L.E., S. Shin, and J.H. Hwang, Inflammatory Diseases of the Lung Induced by Conventional Cigarette Smoke: A Review. Chest, 2015. 148(5): p. 1307-1322.
51. Ezzie, M.E., et al., Gene expression networks in COPD: microRNA and mRNA regulation. Thorax, 2012. 67(2): p. 122-31.
52. Zeng, Z., et al., MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy. Exp Lung Res, 2018. 44(2): p. 89-97.
53. He, S., et al., Characteristics and potential role of M2 macrophages in COPD. Int J Chron Obstruct Pulmon Dis, 2017. 12: p. 3029-3039.
54. Eapen, M.S., et al., Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox. Expert Rev Respir Med, 2017. 11(10): p. 827-839.
55. Murphy, T.F., S. Sethi, and M.S. Niederman, The role of bacteria in exacerbations of COPD. A constructive view. Chest, 2000. 118(1): p. 204-9.
56. Hill, A.T., et al., Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J, 2017. 49(6).
57. Rodriguez-Roisin, R., Toward a consensus definition for COPD exacerbations. Chest, 2000. 117(5 Suppl 2): p. 398S-401S.
58. Lange, P., et al., Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1). Int J Chron Obstruct Pulmon Dis, 2016. 11 Spec Iss: p. 3-12.